Overview

A Pharmacokinetic Study of Intravitreal Aflibercept Injection in Vitrectomized and Non-vitrectomized Eyes With Wet Age-related Macular Degeneration (DRAW).

Status:
Completed

Trial end date:
2017-07-01

Target enrollment:

Participant gender:

Summary

The main goal is to study way that aflibercept injection behaves in the eye and in the body of patients with wet macular degeneration, in patients who have had previous vitreous removal surgery.

Phase:

Phase 1

Details

Lead Sponsor:

University of Nebraska

Collaborator:

Regeneron Pharmaceuticals

Treatments:

Aflibercept